These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21365512)
1. Is minimal change esophagitis really part of the spectrum of endoscopic findings of gastroesophageal reflux disease? A prospective, multicenter study. Kim JH; Park H; Lee YC; Endoscopy; 2011 Mar; 43(3):190-5. PubMed ID: 21365512 [TBL] [Abstract][Full Text] [Related]
2. Carditis: a relevant marker of gastroesophageal reflux disease. Data from a prospective central European multicenter study on histological and endoscopic diagnosis of esophagitis (histoGERD trial). Pinto D; Plieschnegger W; Schneider NI; Geppert M; Bordel H; Höss GM; Eherer A; Wolf EM; Vieth M; Langner C Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30137321 [TBL] [Abstract][Full Text] [Related]
3. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941 [TBL] [Abstract][Full Text] [Related]
4. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring. Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975 [TBL] [Abstract][Full Text] [Related]
5. [Endoscopic esophagitis findings in patients with gastroesophageal reflux symptoms]. Braghetto I; Rebolledo P; Castoldi F; Herrera M Arq Gastroenterol; 1990; 27(4):169-73. PubMed ID: 2133191 [TBL] [Abstract][Full Text] [Related]
6. Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis. Nakamura T; Shirakawa K; Masuyama H; Sugaya H; Hiraishi H; Terano A Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():19-26. PubMed ID: 15943842 [TBL] [Abstract][Full Text] [Related]
8. Validation study of the Esohisto consensus guidelines for the recognition of microscopic esophagitis (histoGERD Trial). Schneider NI; Plieschnegger W; Geppert M; Wigginghaus B; Hoess GM; Eherer A; Wolf EM; Rehak P; Vieth M; Langner C Hum Pathol; 2014 May; 45(5):994-1002. PubMed ID: 24746203 [TBL] [Abstract][Full Text] [Related]
9. [Patients with pathologic gastroesophageal reflux without erosive esophagitis: correlation of the endoscopic and histological aspect of the esophagus]. Csendes A; Smok G; Alvarez F; Braghetto I; Blanco C Rev Med Chil; 1994 Feb; 122(2):159-63. PubMed ID: 8085079 [TBL] [Abstract][Full Text] [Related]
10. Effect of gluten-free diet on preventing recurrence of gastroesophageal reflux disease-related symptoms in adult celiac patients with nonerosive reflux disease. Usai P; Manca R; Cuomo R; Lai MA; Russo L; Boi MF J Gastroenterol Hepatol; 2008 Sep; 23(9):1368-72. PubMed ID: 18853995 [TBL] [Abstract][Full Text] [Related]
11. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Rezailashkajani M; Roshandel D; Shafaee S; Zali MR Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061 [TBL] [Abstract][Full Text] [Related]
13. A critical assessment of the current status of non-erosive reflux disease. Armstrong D Digestion; 2008; 78 Suppl 1():46-54. PubMed ID: 18832840 [TBL] [Abstract][Full Text] [Related]
15. Management of symptoms of gastroesophageal reflux disease: does endoscopy influence medical management? Ellis KK; Oehlke M; Helfand M; Lieberman D Am J Gastroenterol; 1997 Sep; 92(9):1472-4. PubMed ID: 9317065 [TBL] [Abstract][Full Text] [Related]
16. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease. Pace F; Pace M Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016 [TBL] [Abstract][Full Text] [Related]
17. [Non-erosive reflux disease in endoscopy and histopathology]. Błaszak A; Wojtuń S; Gil J; Wojtkowiak M; Dyrla P; Jałocha Ł; Dabek A; Kozłowski W Pol Merkur Lekarski; 2009 May; 26(155):399-402. PubMed ID: 19606683 [TBL] [Abstract][Full Text] [Related]
18. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. Danjo A; Yamaguchi K; Fujimoto K; Saitoh T; Inamori M; Ando T; Shimatani T; Adachi K; Kinjo F; Kuribayashi S; Mitsufuji S; Fujiwara Y; Koyama S; Akiyama J; Takagi A; Manabe N; Miwa H; Shimoyama Y; Kusano M J Gastroenterol Hepatol; 2009 Apr; 24(4):633-8. PubMed ID: 19220681 [TBL] [Abstract][Full Text] [Related]
19. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Wu JC; Cheung CM; Wong VW; Sung JJ Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961 [TBL] [Abstract][Full Text] [Related]
20. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration. de Leone A; Tonini M; Dominici P; Grossi E; Pace F; Dig Liver Dis; 2010 Nov; 42(11):785-90. PubMed ID: 20452300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]